N-[4-(5-fluoro-1,3-benzoselenazol-2-yl)-2-(2-trimethylsilylethynyl)phenyl]acetamide
C20H19FN2OSeSi — CID 152544721
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-(5-fluoro-1,3-benzoselenazol-2-yl)-2-(2-trimethylsilylethynyl)phenyl]acetamide
N-[4-(5-fluoro-1,3-benzoselenazol-2-yl)-2-(2-trimethylsilylethynyl)phenyl]acetamide (PubChem CID 152544721) has the molecular formula C20H19FN2OSeSi and a molecular weight of 429.43 g/mol. Its IUPAC name is N-[4-(5-fluoro-1,3-benzoselenazol-2-yl)-2-(2-trimethylsilylethynyl)phenyl]acetamide.
Molecular Properties
| Compound Name | N-[4-(5-fluoro-1,3-benzoselenazol-2-yl)-2-(2-trimethylsilylethynyl)phenyl]acetamide |
|---|---|
| PubChem CID | 152544721 |
| Molecular Formula | C20H19FN2OSeSi |
| Molecular Weight | 429.43 g/mol |
| Exact Mass | 430.04 |
| IUPAC Name | N-[4-(5-fluoro-1,3-benzoselenazol-2-yl)-2-(2-trimethylsilylethynyl)phenyl]acetamide |
| SMILES | CC(=O)Nc1ccc(-c2nc3cc(F)ccc3[se]2)cc1C#C[Si](C)(C)C |
| InChI | InChI=1S/C20H19FN2OSeSi/c1-13(24)22-17-7-5-15(11-14(17)9-10-26(2,3)4)20-23-18-12-16(21)6-8-19(18)25-20/h5-8,11-12H,1-4H3,(H,22,24) |
| InChIKey | YMFWLIIWVBRWRW-UHFFFAOYSA-N |
| XLogP | 4.29 |
| TPSA | 41.99 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 429.43 |
| LogP ≤ 5 | 4.29 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 152544721 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.